Einstein & Montefiore Investigators Present Research at American Diabetes Association Scientific Sessions
Abstracts to be Presented Focus on Adolescent Issues, Obesity and Genetics
NEW YORK (June 9, 2014) – Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest research at the American Diabetes Association’s 74th Scientific Sessions. Einstein-Montefiore scientists and clinicians are participating in nearly three dozen presentations, sessions and symposia during the five-day meeting. They will address a range of basic, translational and clinical research topics—from medication adherence in adolescents and the impact on resveratrol and vitamin D on insulin resistance to epigenetic and genetic triggers for the disease. ADA will takes place June 13-17 at the Moscone Center in San Francisco, California.
Among the highlights are symposia featuring:
- Jill Crandall, M.D., professor of clinical medicine at Einstein and attending physician, endocrinology at Montefiore, on the most recent findings from the ongoing Diabetes Prevention Program Outcomes Study (Mon., June 16 at 8:00 a.m.)
- Maureen Charron, Ph.D., professor of biochemistry at Einstein, on the role of glucagon in metabolic homeostasis (Fri., June 13 at 2:00 p.m.)
- Rajat Singh, M.D., assistant professor of medicine at Einstein, on the role of autophagy in diabetes (Sat., June 14 at 2:15 p.m.)
- Judith Wylie-Rosett, Ed.D., division head, health promotion and nutrition research, department of epidemiology and population health at Einstein, on better approaches to counseling weight loss among obese patients (Tues., June 17 at 7:30 a.m.)
Poster and oral presentations will include:
- Vitamin D Repletion Reduces Adipose Tissue Fibrosis and Improves Insulin. Oral presentation by Akankasha Goyal, M.D., a research fellow in the lab of Meredith Hawkins, M.D., professor of medicine at Einstein and attending physician, endocrinology at Montefiore. Abstract #OR-90, IA-OR02: Adipose Tissue Development and Metabolic Signaling. Sat., June 14, 8:00-10:00 a.m. W-2002 (West Building)
- Distress and Diabetes Treatment Adherence: A Mediating Role for Perceived Control in Adults with Type 2 Diabetes. Poster presented by Jeffrey S. Gonzalez, Ph.D., assistant professor of medicine and epidemiology & population heath at Einstein. Poster #822, GPS01: Saturday General Poster Session. Sat., June 14, 11:30 a.m.-1:30 p.m. Poster Hall (Hall D-North)
- Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight Humans. Oral presentation by Roger Maginley, M.D., a research fellow in the lab of Dr. Hawkins. Abstract #144, AC-OR05: Hypoglycemia – Brain, Muscle, Heart and Opioids. Sun., June 15, 8:00-10:00 a.m., N-132 (North Building)
- Relationship of Self-Esteem to Glycemic Control amongst Minority Adolescents with Type 1 Diabetes. Poster presented by Joslyn Kenowitz, Ph.D. student in lab of Dr. Gonzalez, working in collaboration with Rubina Heptulla, M.B.B.S., chief of pediatric endocrinology at Einstein and Montefiore. Poster #64-LB, Late Breaking Poster Session. Sun., June 15, 12:00-2:00 p.m., Poster Hall (Hall D-North)
- Exposure to a Maternal High Fat Milieu Alters Hepatic and White Adipose Epigenome in Mice. Poster presented by Maureen Charron, Ph.D., professor of biochemistry at Einstein. Poster #1806, GPS03: Monday General Poster Session. Mon., June 16, 12:00-2:00 p.m., Poster Hall (Hall D-North).
- FTO Genetic Variants, Dietary Intakes, and Adiposity: Results from Over 16,000 Children and Adolescents. Oral presentation by Qibin Qi, Ph.D., assistant professor of epidemiology and population health at Einstein. Abstract #382-OR, CT-OR14: ADA Presidents Oral Session. Tues., June 17, 9:45-11:45 a.m., N-134 (North Building)
Einstein-Montefiore investigators are available to speak about their research and other topics of interest upon request.